サマリー

CTLA4（細胞傷害性Tリンパ球関連タンパク質4）阻害剤の世界市場 2024-2028
ctla4（細胞傷害性Tリンパ球関連タンパク質4）阻害剤市場は、2023年から2028年にかけて22億3000万米ドルの成長が予測され、予測期間中のCAGRは15.11%で加速すると予測されています。当レポートでは、ctla4 (cytotoxic t-lymphocyte-associated protein 4)阻害剤市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。CLTA4阻害剤の高い標的親和性と特異性、併用療法の人気の高まり、CLTA4阻害剤開発における戦略的提携などが市場を牽引しています。
TechnavioのCLTA4（細胞傷害性tリンパ球関連タンパク質4）阻害剤市場は以下のように区分される：
タイプ別
- 単剤療法
- 併用療法
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、CLTA4（細胞傷害性tリンパ球関連タンパク質4）阻害剤市場の今後数年間の成長を促進する主な理由の一つとして、CLTA4の研究適応の拡大を挙げている。また、CLTA4阻害剤の特効薬指定やがんに対する意識の高まりは、市場の大きな需要につながるだろう。
本レポートでは、CLTA4（細胞傷害性t-リンパ球関連タンパク質4）阻害剤市場について、以下の領域をカバーしています：
- CLTA4（細胞傷害性Tリンパ球関連タンパク質4）阻害剤市場のサイジング
- CLTA4（細胞傷害性Tリンパ球関連タンパク質4）阻害剤市場予測
- CLTA4（細胞傷害性Tリンパ球関連タンパク質4）阻害剤市場の産業分析
本レポートでは、CLTA4（細胞傷害性t-リンパ球関連タンパク質4）阻害剤市場の主要ベンダーの詳細な分析を掲載しています。主要ベンダーには、AstraZeneca Plc、Bio Techne Corp、BioNTech SE、Bristol Myers Squibb Co.Ltd.、Merck and Co.Ltd.、江蘇恒瑞医薬有限公司、Merck and Co.Ltd.、上海佛山医薬集団有限公司、Xencor Inc.Ltd.、Xencor Inc.、Agenus Inc.、Akeso Inc.、Innovent Biologics Inc.、Molecular Templates Inc.、TRACON Pharmaceuticals Inc.、XILIO THERAPEUTICS INC.また、CLTA4（細胞傷害性tリンパ球関連タンパク質4）阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/ctla4-cytotoxic-t-lymphocyte-associated-protein-4-inhibitors-market-size-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global CTLA4 (cytotoxic T-lymphocyte-associated protein 4) inhibitors market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global ctla4 (cytotoxic t-lymphocyte-associated protein 4) inhibitors market 2018 - 2022 ($ million)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.3 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Monotherapy - Market size and forecast 2023-2028
o Exhibit 34: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
o 6.4 Combination therapy - Market size and forecast 2023-2028
o Exhibit 38: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies - Market size and forecast 2023-2028
o Exhibit 48: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o 7.4 Retail pharmacies - Market size and forecast 2023-2028
o Exhibit 52: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies - Market size and forecast 2023-2028
o Exhibit 56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ million)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 Canada - Market size and forecast 2023-2028
o Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 China - Market size and forecast 2023-2028
o Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Agenus Inc.
o Exhibit 111: Agenus Inc. - Overview
o Exhibit 112: Agenus Inc. - Product / Service
o Exhibit 113: Agenus Inc. - Key offerings
o 12.4 Akeso Inc.
o Exhibit 114: Akeso Inc. - Overview
o Exhibit 115: Akeso Inc. - Product / Service
o Exhibit 116: Akeso Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 117: AstraZeneca Plc - Overview
o Exhibit 118: AstraZeneca Plc - Product / Service
o Exhibit 119: AstraZeneca Plc - Key news
o Exhibit 120: AstraZeneca Plc - Key offerings
o 12.6 Bio Techne Corp.
o Exhibit 121: Bio Techne Corp. - Overview
o Exhibit 122: Bio Techne Corp. - Business segments
o Exhibit 123: Bio Techne Corp. - Key offerings
o Exhibit 124: Bio Techne Corp. - Segment focus
o 12.7 BioNTech SE
o Exhibit 125: BioNTech SE - Overview
o Exhibit 126: BioNTech SE - Key offerings
o 12.8 Bristol Myers Squibb Co.
o Exhibit 127: Bristol Myers Squibb Co. - Overview
o Exhibit 128: Bristol Myers Squibb Co. - Product / Service
o Exhibit 129: Bristol Myers Squibb Co. - Key news
o Exhibit 130: Bristol Myers Squibb Co. - Key offerings
o 12.9 HBM Holdings Ltd.
o Exhibit 131: HBM Holdings Ltd. - Overview
o Exhibit 132: HBM Holdings Ltd. - Product / Service
o Exhibit 133: HBM Holdings Ltd. - Key offerings
o 12.10 Innovent Biologics Inc.
o Exhibit 134: Innovent Biologics Inc. - Overview
o Exhibit 135: Innovent Biologics Inc. - Product / Service
o Exhibit 136: Innovent Biologics Inc. - Key offerings
o 12.11 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
o Exhibit 137: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
o Exhibit 138: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
o Exhibit 139: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 140: Merck and Co. Inc. - Overview
o Exhibit 141: Merck and Co. Inc. - Business segments
o Exhibit 142: Merck and Co. Inc. - Key news
o Exhibit 143: Merck and Co. Inc. - Key offerings
o Exhibit 144: Merck and Co. Inc. - Segment focus
o 12.13 Ono Pharmaceutical Co. Ltd.
o Exhibit 145: Ono Pharmaceutical Co. Ltd. - Overview
o Exhibit 146: Ono Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 147: Ono Pharmaceutical Co. Ltd. - Key offerings
o 12.14 Shanghai Fosun Pharmaceutical Group Co. Ltd.
o Exhibit 148: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Overview
o Exhibit 149: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Business segments
o Exhibit 150: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Key offerings
o Exhibit 151: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Segment focus
o 12.15 TRACON Pharmaceuticals Inc.
o Exhibit 152: TRACON Pharmaceuticals Inc. - Overview
o Exhibit 153: TRACON Pharmaceuticals Inc. - Product / Service
o Exhibit 154: TRACON Pharmaceuticals Inc. - Key offerings
o 12.16 Xencor Inc.
o Exhibit 155: Xencor Inc. - Overview
o Exhibit 156: Xencor Inc. - Product / Service
o Exhibit 157: Xencor Inc. - Key news
o Exhibit 158: Xencor Inc. - Key offerings
o 12.17 XILIO THERAPEUTICS INC.
o Exhibit 159: XILIO THERAPEUTICS INC. - Overview
o Exhibit 160: XILIO THERAPEUTICS INC. - Product / Service
o Exhibit 161: XILIO THERAPEUTICS INC. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global ctla4 (cytotoxic t-lymphocyte-associated protein 4) inhibitors market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Agenus Inc. - Overview
Exhibits112: Agenus Inc. - Product / Service
Exhibits113: Agenus Inc. - Key offerings
Exhibits114: Akeso Inc. - Overview
Exhibits115: Akeso Inc. - Product / Service
Exhibits116: Akeso Inc. - Key offerings
Exhibits117: AstraZeneca Plc - Overview
Exhibits118: AstraZeneca Plc - Product / Service
Exhibits119: AstraZeneca Plc - Key news
Exhibits120: AstraZeneca Plc - Key offerings
Exhibits121: Bio Techne Corp. - Overview
Exhibits122: Bio Techne Corp. - Business segments
Exhibits123: Bio Techne Corp. - Key offerings
Exhibits124: Bio Techne Corp. - Segment focus
Exhibits125: BioNTech SE - Overview
Exhibits126: BioNTech SE - Key offerings
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key news
Exhibits130: Bristol Myers Squibb Co. - Key offerings
Exhibits131: HBM Holdings Ltd. - Overview
Exhibits132: HBM Holdings Ltd. - Product / Service
Exhibits133: HBM Holdings Ltd. - Key offerings
Exhibits134: Innovent Biologics Inc. - Overview
Exhibits135: Innovent Biologics Inc. - Product / Service
Exhibits136: Innovent Biologics Inc. - Key offerings
Exhibits137: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
Exhibits138: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
Exhibits139: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
Exhibits140: Merck and Co. Inc. - Overview
Exhibits141: Merck and Co. Inc. - Business segments
Exhibits142: Merck and Co. Inc. - Key news
Exhibits143: Merck and Co. Inc. - Key offerings
Exhibits144: Merck and Co. Inc. - Segment focus
Exhibits145: Ono Pharmaceutical Co. Ltd. - Overview
Exhibits146: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibits147: Ono Pharmaceutical Co. Ltd. - Key offerings
Exhibits148: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Overview
Exhibits149: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Business segments
Exhibits150: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Key offerings
Exhibits151: Shanghai Fosun Pharmaceutical Group Co. Ltd. - Segment focus
Exhibits152: TRACON Pharmaceuticals Inc. - Overview
Exhibits153: TRACON Pharmaceuticals Inc. - Product / Service
Exhibits154: TRACON Pharmaceuticals Inc. - Key offerings
Exhibits155: Xencor Inc. - Overview
Exhibits156: Xencor Inc. - Product / Service
Exhibits157: Xencor Inc. - Key news
Exhibits158: Xencor Inc. - Key offerings
Exhibits159: XILIO THERAPEUTICS INC. - Overview
Exhibits160: XILIO THERAPEUTICS INC. - Product / Service
Exhibits161: XILIO THERAPEUTICS INC. - Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations